Norpace (Carilion Materials Management)


Welcome to the PulseAid listing for the Norpace drug offered from Carilion Materials Management. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Carilion Materials Management
NON-PROPRIETARY NAME: disopyramide phosphate
SUBSTANCE NAME: DISOPYRAMIDE PHOSPHATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, GELATIN COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1982-07-20
END MARKETING DATE: 0000-00-00


Norpace HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNorpace from Carilion Materials Management
LABELER NAME: Carilion Materials Management
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 1982-07-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68151-0526_eee23048-2a09-4791-b57c-f61b8458ec92
PRODUCT NDC: 68151-0526
APPLICATION NUMBER: NDA018655

Other DISOPYRAMIDE PHOSPHATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Disopyramide Phosphate
AvKARE, Inc.Disopyramide Phosphate
Carilion Materials ManagementNorpace
G.D. Searle LLC Division of Pfizer IncNorpace CR
Mayne Pharma Inc.Disopyramide Phosphate
Teva Pharmaceuticals USA IncDisopyramide Phosphate